FindTrial
Sign In

Role of procalcitonin in Neuroinfection in newborn

Cerebrospinal fluid procalcitonin as diagnostic biomarker in neonatal meningitis.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2018/09/015720
Enrollment
113
Registered
2018-09-14
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G009- Bacterial meningitis, unspecified

Interventions

None listed

Sponsors

Indira Gandhi institute of child health
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Neonates whose parents are willing to give written informed consent 2. All suspected cases of neonatal meningitis

Exclusion criteria

Exclusion criteria: 1.Neonates who had received antibiotics for >3 days 2. Recent brain surgery/ventricular tap 3. Moribound condition in which life expectancy 4. Grossly traumatic taps 5. Massive stress (severe trauma, surgery, cardiac shock and burns) 6. Parents who refused to give consent

Design outcomes

Primary

MeasureTime frame
To assess CSF procalcitonin as a diagnostic biomarker in neonatal meningitis and assign appropriate cut offs based on ROC curve â?¢ To estimate the levels of CSF procalcitonin in suspected case of meningitis Timepoint: 18 months—

Secondary

MeasureTime frame
To estimate the levels of CSF procalcitonin in suspected case of meningitis Timepoint: 18 months—

Countries

India

Contacts

Public ContactDr Meghana N

Indira Gandhi Institute of Child health

drniranjan_hs@yahoo.com9448046435

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026